These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

727 related articles for article (PubMed ID: 26311425)

  • 1. Neuroprotection of Coenzyme Q10 in Neurodegenerative Diseases.
    Yang X; Zhang Y; Xu H; Luo X; Yu J; Liu J; Chang RC
    Curr Top Med Chem; 2016; 16(8):858-66. PubMed ID: 26311425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coenzyme Q10: a review of its promise as a neuroprotectant.
    Young AJ; Johnson S; Steffens DC; Doraiswamy PM
    CNS Spectr; 2007 Jan; 12(1):62-8. PubMed ID: 17192765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coenzyme Q10 administration and its potential for treatment of neurodegenerative diseases.
    Beal MF
    Biofactors; 1999; 9(2-4):261-6. PubMed ID: 10416039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coenzyme Q treatment of neurodegenerative diseases of aging.
    Galpern WR; Cudkowicz ME
    Mitochondrion; 2007 Jun; 7 Suppl():S146-53. PubMed ID: 17485247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coenzyme Q10 in neuromuscular and neurodegenerative disorders.
    Mancuso M; Orsucci D; Volpi L; Calsolaro V; Siciliano G
    Curr Drug Targets; 2010 Jan; 11(1):111-21. PubMed ID: 20017723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coenzyme Q10 a mitochondrial restorer for various brain disorders.
    Pradhan N; Singh C; Singh A
    Naunyn Schmiedebergs Arch Pharmacol; 2021 Nov; 394(11):2197-2222. PubMed ID: 34596729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotective effects of coenzyme Q10 on paraquat-induced Parkinson's disease in experimental animals.
    Attia HN; Maklad YA
    Behav Pharmacol; 2018 Feb; 29(1):79-86. PubMed ID: 28902670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipophilic antioxidants in neurodegenerative diseases.
    Chang KH; Cheng ML; Chiang MC; Chen CM
    Clin Chim Acta; 2018 Oct; 485():79-87. PubMed ID: 29940147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial dysfunction and oxidative damage in Alzheimer's and Parkinson's diseases and coenzyme Q10 as a potential treatment.
    Beal MF
    J Bioenerg Biomembr; 2004 Aug; 36(4):381-6. PubMed ID: 15377876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of mitochondria in neuronal cell death induced by oxidative stress; neuroprotection by Coenzyme Q10.
    Somayajulu M; McCarthy S; Hung M; Sikorska M; Borowy-Borowski H; Pandey S
    Neurobiol Dis; 2005 Apr; 18(3):618-27. PubMed ID: 15755687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting mitochondrial dysfunction and neurodegeneration by means of coenzyme Q10 and its analogues.
    Orsucci D; Mancuso M; Ienco EC; LoGerfo A; Siciliano G
    Curr Med Chem; 2011; 18(26):4053-64. PubMed ID: 21824087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective Effects of Coenzyme Q10 Against Hydrogen Peroxide-Induced Oxidative Stress in PC12 Cell: The Role of Nrf2 and Antioxidant Enzymes.
    Li L; Du J; Lian Y; Zhang Y; Li X; Liu Y; Zou L; Wu T
    Cell Mol Neurobiol; 2016 Jan; 36(1):103-11. PubMed ID: 26072159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coenzyme Q10 in neurodegenerative diseases.
    Shults CW
    Curr Med Chem; 2003 Oct; 10(19):1917-21. PubMed ID: 12871093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coenzyme Q10 ameliorates oxidative stress and prevents mitochondrial alteration in ischemic retinal injury.
    Lee D; Kim KY; Shim MS; Kim SY; Ellisman MH; Weinreb RN; Ju WK
    Apoptosis; 2014 Apr; 19(4):603-14. PubMed ID: 24337820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coenzyme Q
    Gasmi A; Bjørklund G; Mujawdiya PK; Semenova Y; Piscopo S; Peana M
    Crit Rev Food Sci Nutr; 2024; 64(12):3907-3919. PubMed ID: 36300654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coenzyme Q10 in the central nervous system and its potential usefulness in the treatment of neurodegenerative diseases.
    Beal MF; Matthews RT
    Mol Aspects Med; 1997; 18 Suppl():S169-79. PubMed ID: 9266519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Review of the Common Neurodegenerative Disorders: Current Therapeutic Approaches and the Potential Role of Bioactive Peptides.
    Singh K; Gupta JK; Kumar S; Soni U
    Curr Protein Pept Sci; 2024; 25(7):507-526. PubMed ID: 38561605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose ranging and efficacy study of high-dose coenzyme Q10 formulations in Huntington's disease mice.
    Smith KM; Matson S; Matson WR; Cormier K; Del Signore SJ; Hagerty SW; Stack EC; Ryu H; Ferrante RJ
    Biochim Biophys Acta; 2006 Jun; 1762(6):616-26. PubMed ID: 16647250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PPARγ as a therapeutic target to rescue mitochondrial function in neurological disease.
    Corona JC; Duchen MR
    Free Radic Biol Med; 2016 Nov; 100():153-163. PubMed ID: 27352979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical utility of neuroprotective agents in neurodegenerative diseases: current status of drug development for Alzheimer's, Parkinson's and Huntington's diseases, and amyotrophic lateral sclerosis.
    Dunkel P; Chai CL; Sperlágh B; Huleatt PB; Mátyus P
    Expert Opin Investig Drugs; 2012 Sep; 21(9):1267-308. PubMed ID: 22741814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.